echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Nutrients: Lactobacillus acidophilus DDS-1 and Bifidobacteria lactic acid UABla-12 can improve the severity and symptoms of abdominal pain in IBS patients

    Nutrients: Lactobacillus acidophilus DDS-1 and Bifidobacteria lactic acid UABla-12 can improve the severity and symptoms of abdominal pain in IBS patients

    • Last Update: 2021-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Irritable bowel syndrome (IBS) is a gastrointestinal functional disorder characterized by chronic or recurrent abdominal pain and changes in bowel habits.
    systematic review showed that probiotics were effective in improving IBS symptoms, but the heterogeneity between studies was significant, hindering the development of optimal probiotic strategies for IBS patients.
    , more good randomized controlled trials are needed.
    recently, a randomized, double-blind, placebo-controlled, multi-center study published in Nutrinents showed that L. acidophilus DDS-1 and B. lactic acid bacteria UABla-12 improved IBS symptoms in IBS adults.
    study investigated the clinical efficacy of two probiotic strains on the severity and symptoms of abdominal pain in irritable bowel syndrome (IBS).
    according to the Roman IV standard, 330 IBS adults aged 18-70 were randomly assigned (1:1:1) to receive a placebo, Lactobacillus acidophilus DDS-1 (1×1010 CFU/day) or animal Bifidobacteria subsethic Lactobacillus UABla-12 (1×1010 CFU/day) for six weeks.
    result of this is a change in abdominal pain severity-numerical score sheet (APS-NRS).
    results showed that both groups of probiotics significantly improved the absolute value of APS-NRS (DDS-1:-2.59±2.07, p-0.001; UABla-12:-1.5) during the intervention. 6±1.83, p s 0.001) and percentage of significant responders (DDS-1:52.3%, p slt;0.001);
    DDS-1 (-133.4±95.19, p<0.001) and Lactobacillus Lactobacillus UABla-12 (-104.5) ± IBS-SSS scores in the IBS-SSS group of 96.08, p<0.001) were significantly improved compared to placebos, including sub-scores associated with abdominal pain, bloating, detox habits, and quality of life.
    , the stool viscosity of both groups of probiotic patients was significantly normalized over time compared to placebo.
    , the results showed that L. acidophilus DDS-1 and B. lactic acid bacteria UABla-12 improved the abdominal pain and symptom severity scores of IBS adults and normalized the detox habits of patients accordingly.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.